Emotional Reaction and Self Injury in Patients With Borderline Personality Disorder and Healthy Controls

May 11, 2017 updated by: Katharina Bachmann

Emotional Reaction of Patients With Borderline Personality Disorder (BPD)on Stimuli Connected to Self-injury - A Comparison Between Patients With BPD and a Healthy Control Group.

The current study investigates the emotional response of patients with borderline personality disorder and healthy controls on stimuli associated with self-injury.

Study Overview

Status

Unknown

Intervention / Treatment

Study Type

Observational

Enrollment (Anticipated)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Bad Zwischenahn, Germany, 26160
        • Department of Psychiatry and Psychotherapy - University Hospital, University of Oldenburg

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Patients with Borderline personality disorder that are current in treatment in the inpatient dialectical behavioral therapy unit of the universityhospitel or have completed the treatment.

Matched, healthy controls without psychiatric disorders

Description

Inclusion Criteria:

  • Patients that are able to use skills and have some therapy experiences.

Exclusion Criteria:

  • Severe psychiatric comorbidity e.g. psychosis, severe depression, suicidality

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Other
  • Time Perspectives: Other

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Healthy controls
Different stimuli associated with self-injury are presented. Participants have to rate the emotional effect elected by the stimuli.
Patients with Borderline Personality Disorder
Different stimuli associated with self-injury are presented. Participants have to rate the emotional effect elected by the stimuli.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Emotional reaction
Time Frame: one session of 90min

Patients comparded to healthy controls will show a stronger emotional reaction on the stimuli.

Patients more severely affected will show a stronger emotional reaction compared to less affected patients.

one session of 90min

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Alexandra Philipsen, Prof., Department of Psychiatry and Psychotherapy - University Hospital, University of Oldenburg, Oldenburg, Germany

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Anticipated)

June 1, 2017

Primary Completion (Anticipated)

December 1, 2017

Study Completion (Anticipated)

February 1, 2018

Study Registration Dates

First Submitted

May 9, 2017

First Submitted That Met QC Criteria

May 9, 2017

First Posted (Actual)

May 11, 2017

Study Record Updates

Last Update Posted (Actual)

May 12, 2017

Last Update Submitted That Met QC Criteria

May 11, 2017

Last Verified

May 1, 2017

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Borderline Personality Disorder

Clinical Trials on Stimuli presentation

3
Subscribe